Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - perindopril erbumine, quantity: 8 mg - tablet - excipient ingredients: lactose; microcrystalline cellulose; magnesium stearate; sodium bicarbonate; colloidal anhydrous silica; chlorophyllin-copper complex aluminium lake - perisyl is indicated for: ,1) the treatment of hypertension; ,2) the treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril has not been demonstrated for new york heart association category iv patients); and ,3) patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - perindopril erbumine, quantity: 8 mg - tablet - excipient ingredients: silicon dioxide; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; polacrilin potassium; hydroxypropylbetadex - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril sandoz be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see section 5.1 pharmacodynamic properties), who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - perindopril erbumine, quantity: 8 mg - tablet, uncoated - excipient ingredients: lactose; magnesium stearate - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients).

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - perindopril erbumine -

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - perindopril erbumine -

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

servier laboratories australia pty ltd - perindopril erbumine -

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

servier laboratories australia pty ltd - perindopril erbumine -

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - perindopril erbumine - oral tablet - 4mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - perindopril erbumine - oral tablet - 2mg

Kanada - Kiingereza - Health Canada

apotex inc - perindopril erbumine - tablet - 8mg - perindopril erbumine 8mg - angiotensin-converting enzyme inhibitors